Skip to content
healthcare.dev

Hydromorphone Hydrochloride

NDC 0641-6206, Hydromorphone Hydrochloride, injection, from Hikma Pharmaceuticals USA Inc..

Product NDC
0641-6206
Status
Listed
Labeler
Hikma Pharmaceuticals USA Inc.
Dosage form
INJECTION
Route
INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA216899
DEA schedule
CII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0641-6206 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HYDROMORPHONE HYDROCHLORIDE.5 mg/.5mL

Pharmacologic classes

Full Opioid Agonists [MoA]; Opioid Agonist [EPC]

Package NDCNDC-11Package
0641-6206-100064162061010 SYRINGE in 1 CARTON (0641-6206-10) / .5 mL in 1 SYRINGE (0641-6206-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/31d5a37a-0e90-4e88-be14-75c877be9de2
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0641-6206

Use it

Look up 0641-6206 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0641-6206 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0641-6206. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.